Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to study the implementation and impact of an early warning system to detect and treat sepsis in the emergency room. We are observing the implementation of a Sepsis Machine Learning Model on all Adult patients. All data (observations field notes, interview recording & transcripts, and survey responses) will be stored on HIPAA-compliant Duke servers behind the Duke firewall, and requiring password-protected user authentication to access. The risk to patients is minimal. The two risks to interviewed clinical staff we have identified involve loss of work time and anonymity.


Clinical Trial Description

Sepsis represents a significant burden to the healthcare system. National predictions estimate 751,000 cases of severe sepsis per annum which will increase at a rate of 1.5%. Sepsis accounts for >$23 billion in aggregate hospital costs across all payers and represents nearly 4% of all hospital stays. Six percent of all deaths in the US can be attributed to sepsis. Protocol driven care bundles improve clinical outcomes but require early and accurate detection of sepsis. Unfortunately, identifying sepsis early remains elusive even for experienced clinicians leading to diagnostic uncertainty.

To improve diagnostic consensus, a task force in 2016 agreed upon a new sepsis definition. The task force also included a new risk stratification tool to improve early identification, the quick Sepsis-related Organ Failure Assessment (qSOFA) model, which was more accurate than the older Systemic Inflammatory Response Syndrome (SIRS) in predicting adverse clinical outcomes. However, due to the reliance of end organ dysfunction, the new definition has been criticized for its detection of sepsis late in the clinical course. Clinical decision support tools based on predictive analytics can provide actionable information and improve diagnostic accuracy particularly in sepsis.

Several early warning tools have been described in the published literature based upon predictive analytics and large datasets. One example is the National Early Warning Score (NEWS), which was developed to discriminate patients at risk of cardiac arrest, unplanned intensive care admission, or death. Scores such as NEWS are typically broad in scope and not designed to specifically target sepsis. They are also conceptually simple, as they use only a small number of variables and compare them to normal ranges to generate a composite score. In assigning independent scores to each variable and using only the most recent value, they both ignore complex relationships between the variables and their evolution in time.

In previous work, our group developed a framework to model multivariate time series using multitask Gaussian processes, accounting for the high uncertainty, frequent missing values, and irregular sampling rates typically associated with real clinical data can be read in our prior work. Our machine learning approach is superior to other sepsis detection models that use traditional analytics and machine learning techniques. A custom web application, Sepsis Watch, presents the risk score along with relevant patient information and prompts the user to further evaluate the patient and begin treatment, if appropriate. The Sepsis Watch system is now being implemented by clinical operations at Duke University Hospital.

Our study employs a sequential roll-out study design in the Emergency Department at Duke University Hospital. Our study will involve pods A, B, C, and the Resuscitation Bay. The operational project is not being implemented on the psychiatry wing, fast track, triage or any inpatient encounters. The operational project and thus our study period is based upon a two-phase roll out:

- 1st phase: The predictive model notifies the rapid response team through a dashboard. Nurse notifies team of the risk for sepsis and provides treatment recommendation to primary team and primary team will place orders. Rapid response team nurse documents assessment and actions taken in electronic health record.

- 2nd phase: Improvement and optimization of the workflow integrated in phase 1. One workflow improvement includes the development of an ordering protocol and process whereby the rapid response team can place orders for patients who are deemed appropriate for sepsis treatment. A second workflow improvement includes the development of a clinician feedback and auditing report that would be sent to front-line staff with sepsis bundle compliance performance measures.

In addition to observing patient outcome measures, we propose an additional mixed-methods study component to obtain richer information about the effects of the early warning system on clinicians' situational awareness, decision-making, and workflow. This part of our research will involve (1) gathering data from clinicians through a series of semi-structured interviews, surveys, and observations (2) analysis of this data and identification of relevant patterns and insights. Relevant clinicians include include rapid response team nurses, emergency department (ED) nurses, and ED physicians. These interviews will be conducted in three rounds over the implementation period: before the 1st arm, after the 1st arm, and after the 2nd arm. Electronic surveys will be administered at the end of the 1st arm and the 2nd arm to clinicians. The observations will take place during the 1st and 2nd arms.

The goal of the interviews, surveys, and observations will be to (1) evaluate the effect of the early warning system on the clinicians' situational awareness and decision-making, (2) understand how the early warning system fits into clinician workflow, and, (3) identify opportunities to improve the implementation of the early warning system for future scale-up.

We will be structuring interviews according to the situational awareness model which differentiates between 3 levels of situational awareness: 1) perception of relevant information, 2) comprehension of that information, and 3) anticipation of future events based on that information. Through the interviews, observations, and surveys, we also hope to learn more about clinicians' perceptions of and interactions with the early warning system, and its change on the existing Emergency Department workflow for sepsis diagnosis and management. Data analysis will be conducted with the help of trained qualitative researchers from Data & Society, a research institute in New York City that is focused on the social and cultural issues arising from data-centric technological development. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03655626
Study type Interventional
Source Duke University
Contact
Status Completed
Phase N/A
Start date November 5, 2018
Completion date July 5, 2019

See also
  Status Clinical Trial Phase
Active, not recruiting NCT05095324 - The Biomarker Prediction Model of Septic Risk in Infected Patients
Completed NCT02714595 - Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens Phase 3
Completed NCT03644030 - Phase Angle, Lean Body Mass Index and Tissue Edema and Immediate Outcome of Cardiac Surgery Patients
Completed NCT02867267 - The Efficacy and Safety of Ta1 for Sepsis Phase 3
Completed NCT04804306 - Sepsis Post Market Clinical Utility Simple Endpoint Study - HUMC
Recruiting NCT05578196 - Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections. N/A
Terminated NCT04117568 - The Role of Emergency Neutrophils and Glycans in Postoperative and Septic Patients
Completed NCT03550794 - Thiamine as a Renal Protective Agent in Septic Shock Phase 2
Completed NCT04332861 - Evaluation of Infection in Obstructing Urolithiasis
Completed NCT04227652 - Control of Fever in Septic Patients N/A
Enrolling by invitation NCT05052203 - Researching the Effects of Sepsis on Quality Of Life, Vitality, Epigenome and Gene Expression During RecoverY From Sepsis
Terminated NCT03335124 - The Effect of Vitamin C, Thiamine and Hydrocortisone on Clinical Course and Outcome in Patients With Severe Sepsis and Septic Shock Phase 4
Recruiting NCT04005001 - Machine Learning Sepsis Alert Notification Using Clinical Data Phase 2
Completed NCT03258684 - Hydrocortisone, Vitamin C, and Thiamine for the Treatment of Sepsis and Septic Shock N/A
Recruiting NCT05217836 - Iron Metabolism Disorders in Patients With Sepsis or Septic Shock.
Completed NCT05018546 - Safety and Efficacy of Different Irrigation System in Retrograde Intrarenal Surgery N/A
Completed NCT03295825 - Heparin Binding Protein in Early Sepsis Diagnosis N/A
Not yet recruiting NCT06045130 - PUFAs in Preterm Infants
Not yet recruiting NCT05361135 - 18-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in S. Aureus Bacteraemia N/A
Not yet recruiting NCT05443854 - Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01) Phase 3